THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company
October 17, 2024
THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.
- Buyers
- THL Partners (Thomas H. Lee Partners)
- Targets
- Red Nucleus
- Sellers
- The Riverside Company (Riverside), Riverside Capital Appreciation strategy (RCAF)
- Industry
- Healthcare Services
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
The Riverside Company Acquires Red Nucleus from Renovus Capital Partners
March 24, 2020
Education
The Riverside Company has acquired Red Nucleus Enterprises, LLC, a Yardley, Pennsylvania-based provider of digital learning and regulatory compliance services for the life sciences industry. Renovus Capital Partners sold the company to Riverside but retained a minority equity stake and will continue to support future growth; Riverside plans to expand Red Nucleus's training offerings, technology capabilities and pursue add-on acquisitions.
-
Red Nucleus (RN) / Riverside Acquire AlphaGroup Medical Communications
December 12, 2022
Healthcare Services
Red Nucleus (RN), a portfolio company of The Riverside Company, has acquired AlphaGroup Medical Communications, LLC as an add-on to RN's medical communications business unit. The acquisition expands RN's publications, medical affairs and HEOR/RWE capabilities and brings AlphaGroup's therapeutic expertise and scientific staff into the combined business.
-
Red Nucleus (backed by The Riverside Company) Acquires Life Science Training Institute (LSTI)
September 14, 2020
Healthcare Services
Red Nucleus, a life-sciences learning and training platform backed by The Riverside Company, acquired Life Science Training Institute (LSTI), a provider of on-demand, live, and custom compliance training for pharmaceutical, biotech and medical device customers. The add-on transaction (closed September 2020) expands Red Nucleus's R&D e-learning and compliance capabilities and brings LSTI's subscription library of over 200 courses into RN's platform.
-
Red Nucleus / Riverside Invests in Human Element Solutions (element H)
February 21, 2023
Healthcare Services
Red Nucleus (RN), backed by The Riverside Company, acquired Human Element Solutions, LLC (element H) in February 2023 as an add-on to the RN platform. The acquisition brings element H's meeting and event production, creative communications, video and digital content capabilities into RN's learning & development business to expand services for biotech, pharmaceutical and medical device customers.
-
Red Nucleus / Riverside Acquire INVIVO Communications
September 30, 2020
Healthcare Services
Red Nucleus, the life-sciences learning and performance platform backed by The Riverside Company, acquired Toronto-based INVIVO Communications, a digital scientific communications agency. The deal is an add-on to Riverside's Red Nucleus platform, expanding RN's medical communications and digital scientific communications capabilities; the combined business now totals 360+ employees across seven locations.
-
Red Nucleus Acquires Jupiter Life Science Consulting
September 12, 2022
Consulting
Red Nucleus, a Riverside-backed life sciences services platform, has acquired Jupiter Life Science Consulting, a boutique provider of market access and commercialization strategies for pharma, biotech, and medical device clients. The add-on expands Red Nucleus's commercial and market-access capabilities, bringing Jupiter's expertise in payer research, pricing and access strategy, and commercialization planning into the combined platform.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.